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Abstract
Background: Studies showed that long-standing smokers have stiffer arteries at rest. However, the effect of smoking on the
ability of the vascular system to respond to increased demands (physical stress) has not been studied. The purpose of this
study was to estimate the effect of smoking on arterial stiffness and subendocardial viability ratio, at rest and after acute
exercise in young healthy individuals.
Methods/Results: Healthy light smokers (n=24, pack-years=2.9) and non-smokers (n=53) underwent pulse wave analysis
and carotid-femoral pulse wave velocity measurements at rest, and 2, 5, 10, and 15 minutes following an exercise test to
exhaustion. Smokers were tested, 1) after 12h abstinence from smoking (chronic condition) and 2) immediately after
smoking one cigarette (acute condition). At rest, chronic smokers had higher augmentation index and lower aortic pulse
pressure than non-smokers, while subendocardial viability ratio was not significantly different. Acute smoking increased
resting augmentation index and decreased subendocardial viability ratio compared with non-smokers, and decreased
subendocardial viability ratio compared with the chronic condition. After exercise, subendocardial viability ratio was lower,
and augmentation index and aortic pulse pressure were higher in non-smokers than smokers in the chronic and acute
conditions. cfPWV rate of recovery of was greater in non-smokers than chronic smokers after exercise. Non-smokers were
also able to achieve higher workloads than smokers in both conditions.
Conclusion: Chronic and acute smoking appears to diminish the vascular response to physical stress. This can be seen as an
impaired ‘vascular reserve’ or a blunted ability of the blood vessels to accommodate the changes required to achieve higher
workloads. These changes were noted before changes in arterial stiffness or subendocardial viability ratio occurred at rest.
Even light smoking in young healthy individuals appears to have harmful effects on vascular function, affecting the ability of
the vascular bed to respond to increased demands.
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Introduction
Arterial stiffness is considered a composite measure of vascular
health and a predictor of cardiovascular events independent of
traditional risk factors; it is caused by structural changes in the
vascular wall, including fibrosis, medial smooth muscle cell
necrosis, breaks in elastin fibers, calcifications, and diffusion of
macromolecules into the arterial wall[1–3]. Notably, in the
Framingham Heart Study, a one standard deviation (SD)
increment in arterial stiffness, as measured by carotid-femoral
pulse wave velocity (cfPWV), the ‘gold standard’, was associated
with a 48% increase in arterial disease risk, independently of
individual vascular risk factors[3]. Furthermore, a meta-analysis
found that an increase in cfPWV by 1 m/s corresponded to an
age-, sex-, and risk factor-adjusted risk increase of 14%, 15%, and
15% in total cardiovascular (CV) events, CV mortality, and all-
cause mortality, respectively[2]. An increase in cfPWV by 1 SD
was associated with respective increases of 47%, 47%, and
42%[2].
Using applanation tonometry, pulse wave analysis (PWA) and
PWV measurements can be performed. PWA can provide
important information about several arterial stiffness and
hemodynamic parameters including augmentation index (AIx)
and subendocardial viability ratio (SEVR), an indicator of
myocardial workload and perfusion (O2 supply vs. de-
mand)[4,5]. Low SEVR has been shown to be associated with
coronary artery disease, decreased coronary flow reserve in
patients with healthy coronary arteries, severity of type I and
type II diabetes, decreased renal function, and a history of
smoking[4–13].
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vascular death and disability around the world[14–16]. While in
general smoking rates have been declining in recent years, they
remain quite high especially in young populations; 26.5% of
people aged 20–34 years smoke in Canada and 21.8% of people
aged 18–24 smoke in the Unites States[17,18]. These figures are
disturbing considering the detrimental impact of smoking. More
recently smoking has been shown to increase arterial stiffness both
acutely and chronically[19]. However, to date, studies have
investigated this effect only on resting arterial stiffness. Nevertheless,
people do not spend their lives at rest, and a good part of the day is
spent doing short bouts of physical activity, some of which are
vigorous (i.e. climbing stairs), producing a physical stress on the
vascular system.
It is conceivable that examination of the response of the arteries
to physical stress, such as acute intense exercise, could offer
additional critical information about vascular health. In some
individuals acute physical stress can reveal cardiovascular
abnormalities that are not present at rest. Quantification of
hemodynamic changes [e.g. PWA, SEVR, PWV parameters] that
occur as the arterial system accommodates for the changes in heart
rate, cardiac output, and blood flow (termed herein ‘arterial stress
test’) allows for comparisons between individuals and over time
within the same person.
The purpose of this study was to estimate the extent to which
chronic (study A) and acute (study B) smoking compromise arterial
stiffness and SEVR at rest and after physical stress in young
healthy individuals. To date, no published studies have assessed
the effect of smoking on arterial stiffness after physical stress. This
is particularly important considering that problematic vascular
responses might be revealed only under physical stress.
Methods
This study was approved by the ethics and scientific reviews
boards of the McGill University Health Centre. Written informed
consent was obtained for all participants.
Participants
Using local university advertisements and recruitment within
the McGill University Health Centre, consecutive young healthy
male light smokers (n=24) and non-smokers (n=53), were
enrolled in the study. Light smoking has variable definitions,
being previously classified as high as #20 cigarettes per day[20].
Based on previous studies which have examined the effect of
smoking on vessel hemodynamics in young healthy subjects with a
mean of 10-16-pack years[21,22], we have set the limit to smoking
#15 cigarettes/day with #8 pack-year smoking history in order to
obtain a population with lighter smoking history. Exclusion criteria
were: previously diagnosed cardiovascular disease, traditional
cardiovascular risk factors, renal disease, inflammatory diseases,
obesity (body mass index, BMI $ 30 kg/m
2), and/or any
conditions/diseases that could affect arterial stiffness and/or
exercise capacity. Furthermore, participants who were on regular
cardioprotective medications or were acutely ill were not eligible to
participate in this study.
Study Design
We performed two studies: study A assessing the chronic effect
and study B assessing the acute effect of smoking on arterial
stiffness and SEVR. Non-smokers performed the arterial stress test
protocol once (see below). For study A (chronic study) smokers
performed the protocol after 12h abstinence from smoking and for
study B (acute study) smokers abstained from smoking for 12h and
then smoked 1 cigarette immediately before performing the
protocol. Studies A and B were performed in a randomized
fashion order. For the acute smoking study, smokers were asked to
smoke 1 full standardized cigarette (nicotine content: 1.1–2.4 mg)
within 5 minutes. All measurements were performed in the
morning.
Arterial Stiffness and Hemodynamic Measurements
Blood pressure was measured using cuff sphygmomanometry
(HEM-705CP, Omron Corp., St. Charles, Illinois, United states)
according to the Canadian Hypertension Education Program
guidelines[23]. PWA, SEVR, and PWV measurements were
performed using applanation tonometry (SphygmoCor, AtCor
Medical, Sydney, Australia). For PWA, an average radial pressure
waveform was generated from 10 sec of sequential radial pressure
waveforms. Using a previously validated generalized transfer
function, the system software calculated an averaged radial artery
waveform (calibrated with brachial systolic and diastolic pressure)
and derived a corresponding aortic pressure waveform [as well as
the aortic pressure and the augmentation index adjusted to a heart
rate of 75 (AIx75)][24,25]. PWA was also used to determine
SEVR [area under the curve (AUC) during diastole/AUC during
systole]. cfPWV was measured using applanation tonometry and a
3-lead electrocardiogram. The validity of the derived aortic
pressures and arterial waveforms has been confirmed by
simultaneously recorded direct arterial measurements (catheteri-
zation) in a large number of participants of different ages and with
different blood pressures at rest, during, and after exercise
(r=0.995, P,0.001)[25–29]. The SphygmoCor system used
herein is highly reproducible (inter- and intra-operator) in both
healthy and diseased populations[30,31].
Information about medical history, current smoking status, and
smoking history were directly queried. Pack-years were calculated;
number of pack-years = (packs smoked per day) x (years as a
smoker) (1 pack is considered as 20 cigarettes). Height, weight, and
waist and hip circumference were recorded.
Arterial Stress Test Protocol
Prior to undergoing the arterial stress test, participants were
asked to abstain from: i) caffeine and ethanol intake for at least
12 h and ii) any strenuous exercise (aerobic or anaerobic) for 24 h.
After 10 minutes of rest in a supine position in a temperature and
humidity controlled environment, brachial blood pressure, PWA,
and cfPWV measurements were performed in duplicate. The
points of measurements were marked to ensure that measurements
were performed on the same spots post-exercise. To induce
physical stress, participants subsequently completed a supervised
incremental treadmill exercise protocol to volitional exhaustion
(Bruce protocol[32]), which has been validated in young healthy
individuals[32]; throughout the test heart rate was monitored.
Participants were deemed to reach maximal exercise capacity
when all three of the following criteria were met: i) the participant
could no longer continue the exercise protocol, ii) a minimum of
19 was reached on the Borg scale[32], and iii) the participant
reached at least 90% of their age-predicted maximum heart rate.
Time to exercise completion was recorded. Immediately post-
exercise, participants rested in a supine position. At 2 minutes
post-exercise, cfPWV was assessed once, and at 5, 10, and 15
minutes post-exercise cfPWV and PWA measurements were each
performed once, in that order. Brachial blood pressure was
measured at the same time points as arterial stiffness measure-
ments in the contralateral arm, after confirmation of absence of
difference in blood pressure between the two arms at rest (,5/
3mmHg for systolic and diastolic blood pressure)[33]. All
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quality control system. The above mentioned protocol constitutes
the ‘arterial stress test’.
Statistical Analysis
SAS version 9.2 software (SAS Institute, 100 SAS Campus Dr,
Cary, NC) was used for all statistical analyses. Demographic
characteristics of smokers and non-smokers were compared on
age, BMI, and waist:hip circumfrence using independent t-tests.
Between-group comparisons (non-smokers and smokers) of resting
parameters were performed using general linear models without
and with adjustment for age and resting mean arterial pressure
(MAP) (except MAP and aortic pulse pressure (PP)) using analysis
of covariance (ANCOVA). Aortic PP and MAP comparisons were
adjusted for age only. Post-exercise and peak change (=greatest
post-exercise value minus resting value) between-group compar-
isons for all parameters except for MAP and aortic PP were
performed in a similar manner but with adjustment for age, resting
MAP, exercise time, and the resting value of the parameter. Aortic
PP and MAP were adjusted for age, exercise time, and resting
aortic PP and resting MAP, respectively. General linear model
repeated measures analysis of variance was used to assess
differences in resting values (with adjustment for MAP) and post-
exercise (with adjustment for exercise time and resting MAP) in
smokers between the chronic condition and acute smoking
condition.
To estimate the impact of smoking on overall vascular function
after physical stress (acute exercise), AUC was calculated from the
resting value for each participant for PWA and PWV measure-
ments[34]. This method provides an estimate of overall vascular
function, a continuous construct that can be measured at discrete
time intervals only, while taking into consideration variations in
AUC that may have occurred due to different values at rest.
Differences in the AUC between non-smokers and smokers in each
different condition were estimated using linear regression adjusting
for age, resting MAP, and maximal exercise time with ANCOVA.
AUC of arterial stiffness parameters were considered the
dependent variables. General linear model repeated measures
analysis of variance was used to assess differences in AUCs in
smokers between the chronic condition and acute smoking
conditions with adjustment for exercise time and resting MAP.
Results
Participant characteristics
Participant demographic information is shown in Table 1. In
comparison to non-smokers, smokers were slightly older (26.066.7
vs. 23.165.4 years, P=0.01). There was no significant difference
between groups with respect to BMI or waist:hip ratio. Smokers
reported smoking 10 cigarettes per day with a 2.9 pack-year
history. Tables 2, 3, and 4 contain arterial stiffness and
hemodynamic parameters at rest and post-exercise in non-
Table 1. Baseline Participant Characteristics.
Smokers
(n=24)
Non-smokers
(n=53) P Value
Age (years) 26.066.7 23.165.4 0.01
BMI (kg/m
2)2 1 . 3 64.2 22.362.2 NS
Waist:Hip Circumference 0.9560.06 0.9460.04 NS
Pack-years* 2.9 [1.0–5.6] 0 ,0.0001
Cigarettes/day* 10 [4.7–12.0] 0 ,0.0001
BMI, body mass index.
All values are mean6standard deviation except where values were not normally
distributed. P values are unadjusted.
*presented as median values [interquartile range].
doi:10.1371/journal.pone.0026151.t001
Table 2. Resting and Post-Exercise Vessel Hemodynamic Parameters - Non-Smokers vs. Chronic Smoking.
P Values
Resting 2 min 5 min 10 min 15 min Resting 2 min 5 min 10 min 15 min
HR Non-S 62.668.0 111.7615.3
& 100.669.5
& 97.769.8
& 95.569.6
& NS NS 0.01 0.02 0.02
CS 61.768.0 104.8615.0
& 91.2610.1
& 88.3610.5
& 86.2610.6
&
Aortic PP Non-S 27.064.7 2 41.1612.7
& 31.069.7
& 27.667.0 0.04 2 NS* NS* 0.02
CS 23.966.5 2 35.065.8
& 26.964.3
& 22.064.6
&
MAP Non-S 82.268.9 94.1612.5
& 81.4610.7 80.368.9 81.768.9 NS NS NS 0.01 0.03
CS 83.268.4 94.2610.8
& 84.269.5 85.667.6 85.667.8
cfPWV Non-S 6.060.7 9.062.0
& 6.661.3
& 6.160.9 6.160.9 NS NS NS NS* NS*
CS 6.361.0 8.861.7
& 7.161.4
& 6.761.0
& 6.761.1
&
AIx75 Non-S 211.4610.0 2 12.967.5
& 6.668.2
& 3.269.2
& 0.04 2 NS 0.01 0.003
CS 23.5610.4 2 10.968.7
& 4.169.8
& 21.069.5
SEVR Non-S 173.4644.8 2 75.6624.9
& 80.7626.4
& 87.0624.8
& NS 2 NS* NS* 0.003
CS 163.7626.8 2 91.1616.7
& 97.8617.4
& 111.6620.9
&
HR, heart rate (beats per minute); Non-S, non-smokers; CS, smokers-chronic smoking condition; PP, pulse pressure (mmHg); MAP, mean arterial pressure (mmHg);
cfPWV, carotid-femoral pulse wave velocity (m/s); AIx75, augmentation index adjusted to heart rate of 75 beats per minute (%); SEVR, subendocardial viability ratio (%)
All values are mean6standard deviation.
*P,0.05 before adjustment.
&P,0.05 against resting value (i.e. this parameter has not recovered to resting levels).
Resting HR, cfPWV, AIx75, and SEVR are adjusted for age and resting MAP. Post-exercise, these variables are adjusted for age, exercise time, resting MAP, and the
corresponding resting parameter.
Resting aortic PP and MAP were adjusted for age. Post-exercise, these variables were adjusted for age, exercise time, and the corresponding resting parameter.
doi:10.1371/journal.pone.0026151.t002
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acute condition. Table 5 contains peak changes (pre-post exercise)
and Table 6 contains AUC data and exercise parameters.
Figures 1, 2, and 3 illustrate the aortic PP, AIx75, and SEVR,
respectively in all 3 groups. Maximum heart rate and exercise time
were significantly higher in non-smokers compared to smokers
under both conditions (P,0.0001 for all). However, in smokers
maximum heart rate did not differ significantly between chronic
and acute conditions, while exercise time was significantly greater
in the chronic condition (P,0.0001).
Table 3. Resting and Post-Exercise Vessel Hemodynamic Parameters - Non-Smokers vs. Acute Smoking.
P Values
Resting 2 min 5 min 10 min 15 min Resting 2 min 5 min 10 min 15 min
HR Non-S 62.668.0 111.7615.3
& 100.669.5
& 97.769.8
& 95.569.6
& ,0.0001 0.05 0.0009 0.0003 0.0001
AS 74.168.7 108.8613.1
& 91.3613.0
& 89.867.8
& 88.867.7
&
Aortic PP Non-S 27.064.7 2 41.1612.7
& 31.069.7
& 27.667.0 NS 2 NS NS* 0.05
AS 27.265.9 2 34.266.8
& 26.365.4 23.364.9
&
MAP Non-S 82.268.9 94.1612.5
& 81.4610.7 80.368.9 81.768.9 0.006 NS 0.07 NS* 0.06
AS 89.167.1 93.969.7
& 85.468.9
& 87.167.6 89.567.1
cfPWV Non-S 6.060.7 9.062.0
& 6.661.3
& 6.160.9 6.160.9 NS* NS NS NS* NS*
AS 6.761.0 9.362.5
& 7.161.3
& 6.861.2 6.660.9
AIx75 Non-S 211.4610.0 2 12.967.5
& 6.668.2
& 3.269.2
& 0.006 2 NS 0.01 0.04
AS 21.067.9 2 9.5610.7
& 3.8610.0
& 1.8610.3
SEVR Non-S 173.4644.8 2 75.6624.9
& 80.7626.4
& 87.0624.8
& ,0.0001 2 NS* NS* 0.01
AS 130.2620.0 2 91.5622.2
& 100.7621.4
& 108.2619.3
&
HR, heart rate (beats per minute); Non-S, non-smokers; AS, smokers-acute condition; PP, pulse pressure (mmHg); MAP, mean arterial pressure (mmHg); cfPWV, carotid-
femoral pulse wave velocity (m/s); AIx75, augmentation index adjusted to heart rate of 75 beats per minute (%); SEVR, subendocardial viability ratio (%).
All values are mean6standard deviation.
*P,0.05 before adjustment.
&P,0.05 against resting value (i.e. this parameter has not recovered to resting levels).
Resting HR, cfPWV, AIx75, and SEVR are adjusted for age and resting MAP. Post-exercise, these variables are adjusted for age, exercise time, resting MAP, and the
corresponding resting parameter.
Resting aortic PP and MAP were adjusted for age. Post-exercise, these variables were adjusted for age, exercise time, and the corresponding resting parameter.
doi:10.1371/journal.pone.0026151.t003
Table 4. Resting and Post-Exercise Vessel Hemodynamic Parameters – Chronic Smoking vs. Acute Smoking.
Smokers-Chronic P Values
Resting 2 min 5 min 10 min 15 min Resting 2 min 5 min 10 min 15 min
HR CS 61.768.0 104.8615.0
& 91.2610.1
& 88.3610.5
& 86.2610.6
& ,0.0001 NS NS NS NS
AS 74.168.7 108.8613.1
& 91.3613.0
& 89.867.8
& 88.867.7
&
Aortic PP CS 23.966.5 2 35.065.8
& 26.964.3
& 22.064.6
& NS* 2 NS NS NS
AS 27.265.9 2 34.266.8
& 26.365.4 23.364.9
&
MAP CS 83.268.4 94.2610.8
& 84.269.5 85.667.6 85.667.8 NS NS NS NS NS*
AS 89.167.1 93.969.7
& 85.468.9
& 87.167.6 89.567.1
cfPWV CS 6.361.0 8.861.7
& 7.161.4
& 6.761.0
& 6.761.1
& NS* NS NS NS NS
AS 6.761.0 9.362.5
& 7.161.3
& 6.861.2 6.660.9
AIx75 CS 23.5610.4 2 10.968.7
& 4.169.8
& 21.069.5 NS* 2 NS NS NS
AS 21.067.9 2 9.5610.7
& 3.8610.0
& 1.8610.3
SEVR CS 163.7626.8 2 91.1616.7
& 97.8617.4
& 111.6620.9
& 0.03 2 NS NS NS
AS 130.2620.0 2 91.5622.2
& 100.7621.4
& 108.2619.3
&
HR, heart rate (beats per minute); CS, smokers-chronic condition; AS, smokers-acute condition; PP, pulse pressure (mmHg); MAP, mean arterial pressure (mmHg); cfPWV,
carotid-femoral pulse wave velocity (m/s); AIx75, augmentation index adjusted to heart rate of 75 beats per minute (%); SEVR, subendocardial viability ratio (%).
All values are mean6standard deviation.
*P,0.05 before adjustment.
&P,0.05 against resting value (i.e. this parameter has not recovered to resting levels).
Resting HR, cfPWV, AIx75, and SEVR are adjusted for resting MAP. Post-exercise, these variables are adjusted for exercise time and the corresponding resting parameter.
Resting aortic PP and MAP were unadjusted. Post-exercise, these variables were adjusted for exercise time and the corresponding resting parameter.
doi:10.1371/journal.pone.0026151.t004
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Chronic Condition vs. Non-Smokers. Table 2 describes
arterial stiffness and hemodynamic parameters at rest and post-
exercise in smokers-chronic condition and non-smokers. Aortic
PP was significantly higher in non-smokers at rest (P=0.04) and
15 minutes (P=0.02) post-exercise after adjustment and at 5 and
10 minutes before adjustment. cfPWV was not significantly
different between groups at rest but was significantly higher in
smokers 10 and 15 minutes post-exercise. However, this effect
was lost after adjustment. Importantly, non-smoker cfPWV
recovered faster; they had recovered to resting values by 10
minutes post-exercise while smokers’ cfPWV remained
significantly higher than their resting cfPWV throughout the
entire post-exercise period. At rest AIx75 was significantly lower
in non-smokers after adjustment, while at 10 and 15 minutes
post-exercise AIx75 was significantly higher in non-smokers after
adjustment. In addition, SEVR was not significantly different
between groups at rest but was significantly lower in non-smokers
post-exercise.
Peak changes (Table 5) were not significantly different between
groups except for AIx75 and SEVR, which were significantly
increased and decreased, respectively in non-smokers before
adjustment.
Study B1 – Smokers
Acute Condition vs. Non-Smokers. Table 3 describes
arterial stiffness and hemodynamic parameters at rest and post-
exercise in smokers in the acute condition and non-smokers. Aortic
PP was significantly different between groups (higher in non-
smokers) at 10 minutes (unadjusted) and 15 minutes post-exercise
(adjusted). Acute smoking increased cfPWV compared to non-
smokers at rest and at 10 and 15 minutes post-exercise. However,
these effects were lost after adjustment. AIx75 was significantly
higher after acute smoking at rest (P=0.006). Although 10 and 15
minutes post-exercise there was a reversal of this trend and non-
smokers had significantly increased AIx75. Indeed, non-smoker
AIx75 had not recovered to resting levels by the end of the arterial
stress test, while after acute smoking, smokers had recovered to
Table 5. Peak Pre-Post Exercise Changes.
Non-smoker (1) Smokers-Chronic (2) Smoker-Acute (3) P values
1 vs. 2 1 vs. 3 2 vs. 3
HR 49.1614.7 43.0612.8 34.7613.1 NS 0.05 NS*
Aortic PP 13.9611.4 10.066.7 6.968.7 NS NS* NS
MAP 11.4610.6 11.0610.0 4.869.7 NS NS* NS*
cfPWV 3.061.9 2.461.2 2.561.8 NS NS NS
AIx75 24.5611.4 14.4610.1 10.5610.2 NS* NS* NS*
SEVR 298.1650.7 272.6622.4 238.6624.3 NS* NS* NS*
HR, heart rate (beats per minute); PP, pulse pressure (mmHg); MAP, mean arterial pressure (mmHg); cfPWV, carotid-femoral pulse wave velocity (m/s); AIx75,
augmentation index adjusted to heart rate of 75 beats per minute (%); SEVR, subendocardial viability ratio (%).
All values are mean6standard deviation.
*P,0.05 before adjustment.
HR, cfPWV, AIx75, and SEVR are adjusted for age, exercise time, resting MAP, and the corresponding resting parameter between non-smokers and the two smoking
groups (1 vs. 2 and 1 vs. 3). Repeated measures between Chronic and Acute smoking groups are adjusted for exercise time and resting MAP (2 vs. 3).
Aortic PP and MAP were adjusted for age, exercise time, and the corresponding resting parameter. Post-exercise, these variables were adjusted for age, exercise time,
and the corresponding resting parameter between non-smokers and the two smoking groups. Repeated measures between Chronic and Acute smoking groups are
adjusted for exercise time and resting MAP.
doi:10.1371/journal.pone.0026151.t005
Table 6. Exercise Parameters and Area Under the Curve.
Non-smokers (1) Smokers - Chronic (2) Smokers – Acute (3) P values
1 vs. 2 1 vs. 3 2 vs. 3
Maximum HR (bpm) 195.069.0 185.769.3 184.6610.2 ,0.0001 ,0.0001 NS
Maximum Exercise Time (mins) 16.1861.6 14.561.3 14.161.4 ,0.0001 ,0.0001 ,0.0001
MAP AUC 211.2673.3 19.7646.1 217.8652.4 0.06 NS NS
cfPWV AUC 7.869.6 9.368.2 5.967 . 3 N SN SN S
AIx75 AUC 191.36100.4 75.7686.7 58.1681.7 0.01 0.006 NS*
SEVR AUC 2884.16297.1 2662.16205.2 2339.36177.9 0.07
& ,0.0001 0.01
HR, heart rate; MAP, mean arterial pressure; cfPWV, carotid-femoral pulse wave velocity; AIx75, augmentation index adjusted to heart rate of 75 beats per minute; SEVR,
subendocardial viability ratio.
Values represented as mean6SD.
*P,0.05 unadjusted.
&P,0.01 unadjusted.
P values for 1 vs. 2 and 1 vs. 3, except MAP, are adjusted for age, resting MAP, and exercise time. MAP is adjusted for age and exercise time. All P values for 2 vs. 3, except
MAP, are adjusted for resting MAP and exercise time. MAP is adjusted for exercise time.
doi:10.1371/journal.pone.0026151.t006
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smokers at rest after adjustment but lower at 5 and 10 minutes
post-exercise (before adjustment) and 15 minutes (with
adjustment).
Peak changes in non-smokers for AIx75, SEVR, aortic PP, and
MAP were all significantly greater compared to smokers - chronic
condition before adjustment.
Study B2 – Smokers
Chronic Condition vs. Smokers - Acute Condition. Acute
smoking compared to chronic smoking significantly decreased
SEVR and increased HR at rest after adjustment. Acute smoking
also increased aortic PP, cfPWV, and AIx75 before adjustment at
rest. There were no significant differences post-exercise except for
significantly increased MAP after acute smoking before
adjustment. Time to recovery for most parameters was similar in
the chronic and the acute condition. However, cfPWV recovered
earlier after acute smoking, likely due to the higher resting cfPWV
compared to the chronic condition.
Peak change differences between chronic and acute smoking
conditions for AIx75, SEVR, aortic PP, and MAP were significant
before adjustment but were lost after adjustment.
AUC Analyses
In order to simplify results we used AUC analyses and
quantified the overall change in arterial stiffness and hemody-
namic parameters over the whole time period of the arterial stress
test (Table 6). AUC analysis showed AIx75 to be higher in non-
smokers compared with smokers (chronic, P=0.01) and after
acute smoking (P=0.006) after adjustment. Non-smokers had a
significantly lower SEVR AUC (more negative, greater decrease
in SEVR after exercise) compared with the chronic and acute
conditions. However, adjusting reduced this to a trend in
smokers-chronic condition (P=0.07), while it remained signifi-
cant between smokers-acute condition and non-smokers
(P,0.0001). After adjustment, SEVR AUC was significantly
higher in the acute condition compared with the chronic
condition (P=0.01). MAP AUC was trending towards a
significant increase in smokers-acute condition compared with
non-smokers after adjustment (P=0.06).
Discussion
We do not spend our lives at rest and physical stresses are a
common occurrence in the daily life of almost every individual.
Therefore, to capture more accurate indicators of disease risk it
may be important to move beyond arterial stiffness and vessel
hemodynamic measurements at rest. In this study, we used a
method to quantify vascular function (at rest and post-exercise)
termed the ‘arterial stress test’. Our findings suggest that while
higher arterial stiffness, aortic PP and lower SEVR at rest is
considered ‘detrimental’, this may not be the case for post-
exercise.
Figure 1. Aortic Pulse Pressure at Rest and Post-Exercise. Aortic pulse pressure at rest and after exercise in non-smokers and smokers in the
chronic and acute conditions. *P,0.05 after adjustment.
doi:10.1371/journal.pone.0026151.g001
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exercise between healthy, light smokers after 12h abstinence from
smoking (Study A – chronic condition) and immediately after
smoking 1 standardized cigarette (Study B – acute condition) and
non-smokers using the arterial stress test. We were able to uncover
extremely interesting differences between smokers and non-
smokers with respect to SEVR, AIx75, and aortic PP. At rest,
SEVR (indicator of O2 supply/demand) was significantly de-
creased after the acute smoking condition compared with non-
smokers and the chronic condition. At several time points post-
exercise the SEVR was significantly different between groups and
there was a stepwise increase in SEVR AUC from non-smokers
(lowest) to smokers-chronic condition, and smokers-acute condi-
tion (highest). This is interesting as this difference in SEVR
between non-smokers and smokers-chronic condition was signif-
icant only after exercise (and not at rest) indicating that the
greatest decrease in O2 supply/demand after physical stress was in
non-smokers. This may appear counter-intuitive as insufficient
cardiac perfusion for a given workload can lead to ischemia.
However, SEVR must reach approximately 50% before there is
considered to be cardiac ischemia[6]. It is likely that the non-
smokers were simply able to stress their cardiovascular system
more to achieve higher workloads (longer exercise time and higher
level in the Bruce protocol) and therefore, bring themselves closer
to the point of ischemia (peak SEVR at 5 minutes post-exercise
was 75.6624.9%) but not actually become ischemic. It is also of
note that acute smoking appeared to blunt the effect of physical
stress on the decrease in SEVR (smaller decrease in AUC).
However, this may be due to the fact that at rest after acute
smoking, SEVR was already reduced. In fact, smokers-chronic
condition and smokers-acute condition reached similar peak
SEVR at 5 minutes post-exercise (91.1616.7% and
91.5622.2%, respectively). However, this was achieved in a
shorter exercise time in smokers-acute condition suggesting that
acute smoking causes a decrease in the maximum attainable
workload.
Aortic PP was found to be significantly higher in non-smokers at
rest and post-exercise compared with chronic smokers while these
differences were only noted post-exercise when compared to the
acute condition. PP can be considered a surrogate for stroke
volume[35,36] and therefore, these differences are likely due to the
increased workloads achieved by non-smokers. Indeed non-
smokers were able to exercise for longer and at a higher stage in
the Bruce protocol. Non-smoker mean maximum exercise time
falls into stage 5, 5.0 miles/hour with 18% incline compared to
both smoking conditions that fall into stage 4, 4.2 miles/hour with
16% incline. These results are in line with a previous study by
Sharman et al. that found PP amplification during exercise is
reduced with age and hypercholesterolemia[37].
Similar to SEVR, AIx75 was significantly elevated in the
chronic and acute conditions compared with non-smokers at rest;
however, after physical stress AIx75 was higher in non-smokers
Figure 2. Augmentation Index at Rest and Post-Exercise. Augmentation index at rest and after exercise in non-smokers and smokers in the
chronic and acute conditions. *P,0.05 after adjustment.
&P,0.01 after adjustment.
doi:10.1371/journal.pone.0026151.g002
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could be a result of non-smokers achieving a higher heart rate or
workload. However, AIx75 is adjusted to a heart rate 75 beats per
minute and this finding remained significant after adjusting for
exercise time.
Smoking causes endothelial dysfunction, increased production
and release of endothelin-1 (ET-1), increased inflammation,
decreased kidney function, insulin resistance, alterations in lipid
metabolism, and increased oxidative stress, which reduces both
production and bioavailability of nitric oxide (NO), and directly
damages endothelial cells[38–42]. Furthermore, acute exercise
causes a redistribution of blood flow to the working muscles caused
by vasodilation of working muscles and vasoconstriction in other
areas such as the splanchnic circulation[43,44]. Exercise has been
shown to increase ET-1 and NO release which play roles in blood
redistribution during exercise[45–49]. Moreover, animal studies
have shown that during exercise, local ET-1 production increases
in the splanchnic circulation and decreases in the coronary
circulation, and NO production increases in the coronary
circulation[50–52]. Therefore, it is possible that after acute
exercise in non-smokers, local production of ET-1 in the
splanchnic and coronary circulations could be greater and lower
than smokers, respectively; this could hold true even if total
circulating ET-1 increases to a greater extent in smokers after
exercise. This differential ET-1 release between vascular beds
combined with greater NO release in the coronary circulation in
non-smokers would allow non-smokers to achieve higher work-
loads bringing the heart closer to ischemia, explaining the lower
SEVR post-exercise. In addition, this may also explain the
increase in AIx75 seen post-exercise; greater vasoconstriction of
the arteries to the gut in non-smokers would increase the number
and magnitude of wave reflections in the aorta and abdominal
aorta. Our findings at rest in smokers and non-smokers are in
accordance with other studies that have also been performed at
rest and have found that increased AIx is associated with CV risk
and low SEVR to be associated with coronary artery disease,
decreased coronary flow reserve in patients with healthy coronary
arteries, severity of type 1 and type 2 diabetes, decreased renal
function, and a history of smoking[6–12].
To our knowledge, no other studies compared these parameters
in smokers and non-smokers after exercise, where different
mechanisms could be implicated. After exercise, lower SEVR
and higher AIx and aortic PP may simply represent a beneficial
physiological response or a greater ‘vascular reserve’ that increases
the ability to perform at higher workloads. Future studies will need
to address the exact mechanisms behind these responses.
We also have found that acute smoking increased cfPWV at
rest, but this effect was lost after adjusting for blood pressure.
Chronic smoking was found to not have a significant effect on
cfPWV at rest (chronic smoking condition vs. non-smokers). This
is in line with a recent study that determined reference values for
cfPWV[53]; they found no significant difference in cfPWV
between middle aged smokers and non-smokers after adjusting
for blood pressure. While there were no significant differences
Figure 3. Subendocardial Viability Ratio at Rest and Post-Exercise. Subendocardial viability ratio at rest and after exercise in non-smokers
and smokers in the chronic and acute conditions. *P,0.05 after adjustment.
&P,0.01 after adjustment.
doi:10.1371/journal.pone.0026151.g003
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find that non-smokers had lower cfPWV before adjustment and a
greater rate of recovery of cfPWV. Non-smokers returned to
resting levels 10 minutes post-exercise while smokers-chronic
condition were not recovered by the end of the arterial stress test.
Smokers-acute condition did recover to resting levels before the
arterial stress test was completed; however, this is due to their
increased resting cfPWV. By enrolling only young, healthy, light
smokers (median pack-years of 2.9) in our study we assessed the
scenario least likely to cause changes in arterial stiffness or vessel
hemodynamics (i.e. minimal vascular damage). Therefore, the
arterial stress test was able to elicit changes in cfPWV in subject
with little vascular damage due to chronic smoking. To our
knowledge this is the first study to capture the acute response of
the vascular system immediately after maximal physical stress by
measuring cfPWV (the ‘gold standard’ measure of arterial
stiffness), and therefore, provides valuable information that can
be used to help design future studies.
Taken together, our findings suggest that the new method we
have used, the arterial stress test, may in the future offer novel
information to better estimate clinical risk and monitor health
status over time, which may be applied to patient groups with
minimal vascular damage. Using the arterial stress test we were
able to elicit evidence of vascular impairment in young healthy
light smokers at an earlier stage, before vascular damage was
detectable at rest. Earlier detection of vascular compromise may
offer opportunities to intervene and attenuate or reverse vascular
dysfunction and cardiovascular risk at an earlier stage. The arterial
stress test may offer the opportunity to move beyond our current
methods of addressing smoking as a binary risk factor (present/
absent), and vascular damage can be quantified directly rather
than inferred indirectly through exposure (e.g. pack-years).
Enhanced risk stratification would allow clinicians to identify
those individuals at higher risk (independently of their smoking
status: current, never, former), monitor them closely, and treat
them aggressively when indicated.
There are limitations in this study. An inherent limitation is the
relatively small sample size (n=77). Yet, despite this we were able
to show significant differences in vessel hemodynamic parameters
between smokers and non-smokers at rest and post-exercise; this
provides evidence for the arterial stress test being an effective
method to elicit even subtle differences in arterial stiffness. Due to
the technical limitations of applanation tonometry, we were not
able to measure arterial stiffness throughout exercise, only
immediately post-exercise. Furthermore, since the time limitations
for measurements post-exercise were strict, we did not perform the
PWA analysis at 2 minutes. We recruited consecutive eligible
subjects and therefore, we did not age-match our subjects, instead
we adjusted for age. We included only men in order to avoid
potential sex effects on vascular response. The ratio of non-
smokers to smokers is 2:1; this resulted in increased power
compared to a 1:1 ratio with n=24 in each group[54]. Blood tests
to measure CV risk factors were not available. Furthermore, this
study is hypothesis generating and the natural first step before
validating the arterial stress test and the ‘vascular reserve’ concepts
in future larger studies with target organ damage and clinical
events as end points. We did not measure VO2max to confirm that
the subjects reached their maximal exercise capacity. However, we
used three well established criteria, as mentioned above[32]. We
also did not have a non-smoker group perform the acute smoking
intervention. However, this was deemed unethical by the McGill
University Health Centre Research Ethics Board.
Conclusions
We have assessed arterial stiffness and hemodynamic parame-
ters before and after exercise using a novel protocol (the arterial
stress test). Young, healthy, light smokers exhibited blunted
decreases in SEVR and blunted increases in AIx75 and aortic
PP after acute physical stress compared with non-smokers. This
shows that even in this relatively healthy population there are
impairments in the ability of the arteries to respond to physical
stress before changes are noted at rest, suggesting that it is possible
to identify the development of vascular damage at an earlier stage
than current tools allow. If this ability to respond to increased
demands of physical stress in non-smokers can be considered a
‘vascular reserve’ remains to be confirmed. Our findings also
indicate that an increase in arterial stiffness or a greater decrease in
SEVR after physical stress may play a beneficial role in the
physiological response to exercise, providing further support for
the need to assess ‘vascular reserve’. This hypothesis will need to
be investigated in future studies. The arterial stress test may be
used in the future to better stratify individual risk, intervene earlier
and attenuate the high rates of morbidity and mortality associated
with smoking and cardiovascular disease.
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